Joanne M. Donovan, CMO at Edgewise Therapeutics, Inc. (EWTX), sold 9,441 shares at $43.78 ($413K) on 2026-08-12, disclosed to the SEC on 2026-08-14.
Scheduled sale ($413k) by CMO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $43.71 | 2,779 | $121K | 29.4% |
| 2 | $43.78 | 2,839 | $124K | 30.1% |
| 3 | $44.43 | 104 | $5K | 1.1% |
| 4 | $44.52 | 800 | $36K | 8.6% |
| 5 | $43.41 | 2,919 | $127K | 30.7% |
| Total | $43.71 avg | 9,441 |
| $413K |
| 100% |
| Filing → |
| EWTX | SELL | 2026-03-31 | $1.4M | — | Filing → |
| EWTX | SELL | 2026-03-30 | $1.0M | — | Filing → |
| EWTX | SELL | 2025-08-14 | $38K | — | Filing → |